Page 224 - Vitamin D and Cancer
P. 224

9  Molecular Biology of Vitamin D Metabolism and Skin Cancer    211

              Knowing  the  consequences  of  vitamin  D  inadequacy,  key  parties  in  Australia
            involved in skin cancer control have decided to provide more updated guidelines to
            the puiblic regarding the importance of UVR in vitamin D synthesis [143]. Apart
            from reminding people of the harmful effects of UVR on skin cancer, the new mes-
            sage to the public stepped away from the idea of needing protection against the sun
            at all times and stressed the importance of maintaining adequate vitamin D levels by
            encouraging outdoor activities (Cancer Council Australia, 2007). However, appro-
            priate  precautions  needs  to  be  taken  during  outdoor  activities  For  incidental  sun
            exposure of less than 10 min, the application of sunscreen may not be necessary, but
            sunscreen application is recommended if periods of sun exposure sufficient to pro-
            duce erythema (redness) are intended [116]. Although it has been found that the use
            of sunscreen can have a negative effect on vitamin D synthesis [105], other clinical
            studies on long term use of sunscreens showed that normal vitamin D levels can still
            be maintained [102, 145]. The use of sunscreen is also encouraged by the fact that
            once previtamin and vitamin D  has been formed, further exposure to sunlight will
                                     3
            cause their degradation into inert over irradiation products [66] and this further UVR
              exposure will only lead to increases in DNA damage. Based on this, it has been
            pragmatically decided that exposure of hands, face and arms to a third to a half of a
            minimum  erythemal  dose  for  5–15  min  four  to  six  times  a  week  with  the  dark
            skinned and elderly population needing the greatest exposure of these  recommended
            values [68, 116]. However, if sun exposure is limited by medical or cultural reasons,
            a tailored vitamin D supplementation plan may be necessary [143].
              Currently,  there  are  still  no  recommended  dietary  intake  levels  in  place  in
            Australia but the daily vitamin D intake recommended by the Food and Nutrition
            Board of the US Institute are 200 IU, 400 IU and 600–800 IU for ages 0–50 years,
            51–70 years and 71+ years respectively [50]. Yet, these recommended values have
            been challenged by the findings that 200 IU/day has no effect on bone status and
            the recommendation of 1,000 IU has been suggested to adequately prevent bone
            disease, fractures and possibly protect against some cancers [159]. Moreover, it has
            even been reported that 800 IU/day supplemented vitamin D did not reduce osteo-
            porotic fractures in some vitamin D replete individuals [135].
              In conclusion, much research is needed to further understand the health benefits
            that accompanying sun exposure. More importantly, it is essential to further eluci-
            date the molecular mechanisms underlying the actions of vitamin D in preventing
            classical diseases relating to bone health as well as non classical diseases such as
            cancer. Such investigations should take into consideration not only different age
            and racial groups, but also their health status including genetical variations in key
            vitamin D metabolizing genes (Fig. 9.3). The findings in these future studies will
            yield invaluable knowledge to aid appropriate recommendations for sun exposure
            and vitamin D intake. These sun exposure levels will also have to take into account
            of keeping the fine balance between UV exposure derived health benefits and pre-
            venting skin cancer. Ultimately, this knowledge can be translated into the develop-
            ment of improved vitamin D analogs to efficiently treat vitamin D related diseases
            with minimal side effects.
   219   220   221   222   223   224   225   226   227   228   229